Clinical Trials on Intracranial Germ Cell CNS Tumor, Childhood in Netherlands
Total 390 results
-
University Medical Center GroningenCompletedNeuroendocrine TumorNetherlands
-
University Medical Center GroningenCompletedNeuroendocrine TumorNetherlands
-
University Medical Center GroningenCompletedNeuroendocrine TumorNetherlands
-
University Medical Center GroningenCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Cancer Research UK; European Organisation for... and other collaboratorsActive, not recruitingSeminoma | Teratoma | Choriocarcinoma | Germinoma | Germ Cell Tumor | Yolk Sac Tumor | Mixed Germ Cell Tumor | Childhood Teratoma | Malignant Germ Cell Neoplasm | Extragonadal Seminoma | Non-seminomatous Germ Cell TumorUnited States, Germany, France, Spain, Netherlands, Australia, Belgium, Switzerland, United Kingdom, Italy, Denmark, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
University Medical Center GroningenCompletedQuality of Life | Distress | Neuroendocrine TumorNetherlands
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Unspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Erasmus Medical CenterRecruitingQuality of Life | Testicular Germ Cell Tumor | Testicular CancerNetherlands
-
European Organisation for Research and Treatment...UnknownTesticular Germ Cell Tumor | Teratoma | Extragonadal Germ Cell TumorFrance, Netherlands, Spain, United Kingdom, Norway, Belgium, Germany, Denmark, Hungary, Slovakia, Israel, Italy, Austria, Poland
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Ovarian Cancer | Extragonadal Germ Cell TumorFrance, Spain, Denmark, Netherlands, Norway, Belgium, United Kingdom, Israel, Italy, Switzerland, Germany, Portugal, Greece, Austria
-
Y-mAbs TherapeuticsTerminatedMedulloblastoma, ChildhoodUnited States, Spain, United Kingdom, Denmark, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingUntreated Childhood MedulloblastomaUnited States, Canada, Australia, New Zealand, Switzerland, Netherlands
-
University Medical Center GroningenCompleted
-
Medical Research CouncilEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedTesticular Germ Cell TumorUnited Kingdom, Canada, Norway, Netherlands, South Africa, Brazil, Finland
-
University Medical Center GroningenCompletedNeuroendocrine TumorsNetherlands
-
University Medical Center GroningenCompletedNeuroendocrine TumorsNetherlands
-
University Medical Center GroningenNovartis PharmaceuticalsCompletedNeuroendocrine TumorsNetherlands
-
Leiden University Medical CenterRecruitingFluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine GreenParagangliomaNetherlands
-
Radboud University Medical CenterRecruiting
-
University Medical Center GroningenRadboud University Medical Center; Maastricht University Medical Center; UMC... and other collaboratorsCompleted
-
University Medical Center GroningenCompletedCarcinoma, Renal Cell | Carcinoma | Neuroendocrine Tumors | Carcinoid Tumor | Pancreatic Islet Cell TumorsNetherlands
-
University Hospital, AntwerpErasmus Medical Center; ZonMw: The Netherlands Organisation for Health Research... and other collaboratorsRecruitingGastroenteropancreatic Neuroendocrine TumorNetherlands, Belgium
-
Advanced Accelerator ApplicationsActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorSpain, United States, United Kingdom, France, Canada, Germany, Netherlands, Italy, Korea, Republic of
-
Radboud University Medical CenterCompleted
-
Erasmus Medical CenterRecruitingNeuroendocrine TumorsNetherlands
-
Radboud University Medical CenterCompleted
-
Galina VelikovaThe Leeds Teaching Hospitals NHS Trust; European Organisation for Research...CompletedQuality of Life | Cognitive Impairment | Health-related Quality of Life | Long-term Effects of Cancer Treatment | WHO Grade II Oligodendroglial Tumor | WHO Grade III Oligodendroglial TumorNetherlands, United Kingdom
-
UMC UtrechtCompletedNeuroendocrine TumorsNetherlands
-
Zuyderland Medisch CentrumRecruiting
-
Zuyderland Medisch CentrumCompleted
-
Radboud University Medical CenterCompleted
-
A.J.M. van den EertweghIdera Pharmaceuticals, Inc.Recruiting
-
The Netherlands Cancer InstituteUniversity of Pavia; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsRecruiting
-
Amsterdam UMC, location VUmcBristol-Myers SquibbRecruiting
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterCompleted
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLCUnknownMetastatic MelanomaNetherlands
-
The Netherlands Cancer Institute4SCActive, not recruiting
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Centre Leon BerardRecruitingChildhood EpendymomaItaly, Denmark, France, Czechia, Sweden, Germany, Slovenia, United Kingdom, Austria, Belgium, Ireland, Netherlands, Norway, Spain, Switzerland
-
Camurus ABActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorUnited States, Belgium, Spain, Netherlands, France, Germany, Israel, Italy, Canada, Australia, Romania, Hungary
-
University of TwenteNot yet recruitingMelanoma (Skin)Netherlands
-
Maastricht University Medical CenterUnknownRenal Cell Carcinoma | Breast Cancer | Neuroendocrine Neoplasm of Lung | Pancreatic Neuroendocrine Tumour | Gastrointestinal Neuroendocrine TumourNetherlands
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Metastatic Cancer | Mediastinal CancerUnited Kingdom, Norway, Switzerland, Spain, Belgium, Netherlands, Germany, Denmark, Slovakia, Italy, Austria, Poland
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Bristol-Myers SquibbCompleted
-
The Netherlands Cancer InstituteRecruiting
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingStage III Skin MelanomaNetherlands
-
The Netherlands Cancer InstituteNot yet recruiting